𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

✍ Scribed by Schapira, Anthony HV; McDermott, Michael P; Barone, Paolo; Comella, Cynthia L; Albrecht, Stefan; Hsu, Helen H; Massey, Daniel H; Mizuno, Yoshikuni; Poewe, Werner; Rascol, Olivier; Marek, Kenneth

Book ID
120391230
Publisher
The Lancet
Year
2013
Tongue
English
Weight
235 KB
Volume
12
Category
Article
ISSN
1474-4465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale for delayed-start study of pra
Rationale for delayed-start study of pramipexole in Parkinson's disease: The PROUD study
✍ Anthony H.V. Schapira; Stefan Albrecht; Paolo Barone; Cynthia L. Comella; Michae πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract Perhaps the most important unmet need in Parkinson's disease (PD) is the ability to slow or prevent progression of the neurodegeneration that underlies the motor and nonmotor features of this disorder. Pramipexole, a dopamine agonist used for the symptomatic treatment of PD, has demonst

Twice-daily, low-dose pramipexole in ear
Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
✍ Karl Kieburtz; The Parkinson Study Group PramiBID Investigators πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, double‐blind, placebo controlled trial involving 311 early PD patients not receiving dopaminer